| Metric | შპს ეიჩბი ფარმ | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾7.5m₾7.2m | ₾2.36bn₾2.11bn |
| Revenue growth | 3.6% | 11.8% |
| Profitability | ||
| EBITDA | -₾385k₾349k | — |
| EBITDA margin | -5.2%4.8% | — |
| Net profit | -₾608k₾281k | ₾1.24bn₾1.12bn |
| Net margin | -8.1%3.9% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾5.7m₾6.3m | ₾37.66bn₾31.77bn |
| Total equity | ₾1.5m₾2.1m | ₾5.45bn₾4.75bn |
| ROE | -41.6%13.6% | 22.8%23.6% |